{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:39:52Z","timestamp":1760204392994,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.jaad.2009.07.042","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T14:56:59Z","timestamp":1255532219000},"page":"957-961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications"],"prefix":"10.1016","volume":"62","author":[{"given":"Jacqueline L.","family":"Gerhart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer N.","family":"Kalaaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2009.07.042_bib1","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1001\/archinte.1995.00430220094010","article-title":"Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993: an analysis of 78 cases","volume":"155","author":"Arend","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2009.07.042_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/CMR.4.2.137","article-title":"Pneumocystis carinii, an opportunist in immunocompromised patients","volume":"4","author":"Bartlett","year":"1991","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaad.2009.07.042_bib3","first-page":"795","article-title":"Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis","volume":"151","author":"Ognibene","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaad.2009.07.042_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh071","article-title":"Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases","volume":"43","author":"Saito","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2009.07.042_bib5","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","article-title":"Pneumocystis carinii pneumonia in patients without AIDS","volume":"17","author":"Sepkowitz","year":"1993","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2009.07.042_bib6","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2009.07.042_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","article-title":"Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients","volume":"21","author":"Roblot","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jaad.2009.07.042_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF02113579","article-title":"Pneumocystis carinii pneumonia in HIV-negative patients with hematologic disease","volume":"25","author":"van der Lelie","year":"1997","journal-title":"Infection"},{"key":"10.1016\/j.jaad.2009.07.042_bib9","first-page":"130","article-title":"Mechanisms of defense in the lung: lessons from Pneumocystis carinii pneumonia","volume":"17","author":"Vassallo","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.jaad.2009.07.042_bib10","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.4065\/71.11.1121","article-title":"Diagnosis of Pneumocystis carinii pneumonia: does use of only bronchoalveolar lavage suffice?","volume":"71","author":"Limper","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2009.07.042_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1053\/srin.2003.50004","article-title":"The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia","volume":"18","author":"Hahn","year":"2003","journal-title":"Semin Respir Infect"},{"key":"10.1016\/j.jaad.2009.07.042_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/PL00021707","article-title":"Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy","volume":"15","author":"Ogawa","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2009.07.042_bib13","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2133.1999.03052.x","article-title":"Pneumocystis carinii pneumonia in patients receiving immunosuppressive drugs for dermatological diseases","volume":"141","author":"Raychaudhuri","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2009.07.042_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/s10165-005-0395-9","article-title":"Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases","volume":"15","author":"Sato","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2009.07.042_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","article-title":"Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy","volume":"71","author":"Yale","year":"1996","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2009.07.042_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2334-4-42","article-title":"Autoimmune inflammatory disorders, systemic corticosteroids and Pneumocystis pneumonia: a strategy for prevention","volume":"4","author":"Sowden","year":"2004","journal-title":"BMC Infect Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209009669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962209009669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:17:51Z","timestamp":1759270671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962209009669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0190962209009669"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2009.07.042","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2009.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}